Prognostic value of the carcinoembryonic antigen found in pleural lavage fluid from patients with lung carcinoma;Valor pronóstico del antígeno carcinoembrionario hallado en lavados pleurales de pacientes con carcinoma pulmonar

Archivos de Bronconeumologia

Volumn 41, Issue 4, 2005, Pages 185-188

  Galbis Caravajal, J M ^a,b   Benlloch Carrion S ^a   Sanchez Paya J ^a   Mafe Madueno J J ^a   Baschwitz Gomez B ^a   Rodriguez Paniagua J M ^a  

^a HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

^b NONE   (Spain)

Author keywords

Carcinoembryonic antigen; Pleural lavage; Pulmonary carcinoma

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ACCURACY; ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HUMAN; INTRAOPERATIVE PERIOD; LUNG CARCINOMA; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MEDICAL PARAMETERS; OBSERVATION; PLEURA EFFUSION; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; STATISTICAL SIGNIFICANCE; THORACIC CAVITY; THORACOTOMY;

EID: 17844376723     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13073167     Document Type: Article

References (15)

1. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997;11:1710-7.
2. Nisman B, Amir G, Lafair J, Heching N, Lyass O, Peretz T, et al. Prognostic value of cyfra 21-1, TPS and CEA in different histologic types of non-small cell lung cancer. Cancer Res. 1999;19: 3549-52.
3. Niklinski J, Furman M. Clinical tumour markers in lung cancer. Eur J Cancer Prev. 1995;4:129-38.
4. Hotta K, Segawa Y, Takigawa N, Kishino D, Saeki H, Nakata M, et al. Evaluation of the relationship between serum carcinoembryonic antigen level and treatment outcome in surgically resected clinical-stage I patients with non-small-cell lung cancer. Cancer Res. 2000;20:2177-80.
5. Villena V, López Encuentra A, Echave J, Martín P, Ortuño B, Estenoz J. Diagnostic value of CA 549 in pleural fluid. Comparison with CEA, CA 15.3 and CA 72.4. Lung Cancer. 2003;40:289-94.
6. Salama G, Miédougué M, Rouzaud P, Mauduyt MA, Pujazon M, Vincent C, et al. Evaluation of pleural cyfra 21-1 and carcinoembryonic antigen in the diagnosis of malignant pleural effusions. Br J Cancer. 1998;77:472-6.
7. Hirsch F, Franklin WA, Gazdar AF, Bunn P. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology. Clin Cancer Res. 2001;7:5-22.
8. Hernández Hernández JR. Importancia y significado de los marcadores tumorales en neumología. Arch Bronconeumol. 1997;33:485-7.
9. Díez M, Torres A, Maestro ML, Ortega MD, Gómez A, Pollán M, et al. Prediction of survival and recurrence by serum and cytosolic levels of CEA, CA 125 and SCC antigens in resectable non-small-cell lung cancer. Br J Cancer. 1996;73:1248-54.
10. Maskell NA, Butland RJA. BTS guidelines for the investigation of a unilateral pleural effusion in adults. Thorax. 2003;58 Suppl 2: 17-23.
11. Dresler CM, Fratelli C, Babb J. Prognostic value of positive pleural lavage in patients with lung cancer resection. Ann Thorac Surg. 1999;67:1435-9.
12. Okada M, Tsubota M, Miyamoto Y, Maniwa Y. Role of pleural lavage cytology before resection for primary lung carcinoma. Ann Surg. 1999;229:579-84.
13. Rubins JB, Dunitz J, Rubins H, Maddaus MA, Niewoehner DE. Serum carcinoembryonic antigen as an adjunct to preoperative staging of lung cancer. J Thorac Cardiovasc Surg. 1998;116:412-6.
14. Hernández L, Espasa A, Fernández C, Candela A, Martín C, Romero S. CEA and CA 549 in serum and pleural fluid of patients with pleural effusion. Lung Cancer. 2002;36:83-9.
15. Ferrer Sancho J. Marcadores tumorales en líquido pleural. Arch Bronconeumol. 2000;36:295-7.